PedAM
Pediatric Disease Annotations & Medicines
| Disease | pancreatic cancer |
| Phenotype | C0001418|adenocarcinoma |
| Sentences | 9 |
| PubMedID- 23826131 | pancreatic cancer cases with pathology confirmed adenocarcinoma were identified from the ontario cancer registry (n = 628) and controls were identified through random digit dialing (n = 1193). |
| PubMedID- 23307416 | Additionally, because expression of oatp1b3 is highest in pancreatitis and stage one adenocarcinoma, which leads to pancreatic cancer, oatp1b3 is a potential marker to diagnose patients with early stage pancreatic adenocarcinomas. |
| PubMedID- 23589669 | In this work, we used cancer data from the surveillance epidemiology and end results (seer) database from 18 geographical areas (san francisco-oakland, connecticut, detroit, hawaii, iowa, new mexico, seattle, utah, atlanta, san jose, los angeles, alaska natives, rural georgia, greater california, kentucky, louisiana, new jersey, and greater georgia).16 these data were published by seer in april 2012 and contain cases diagnosed up to 2009. from this release, we extracted survival data for pancreatic cancer patients diagnosed with adenocarcinoma (international classification of diseases for oncology, 3rd edition histology codes 8140-8149). |
| PubMedID- 25341546 | Selection criteria were admittance to hospital between january 2008 and december 2012, histologically confirmed adenocarcinoma, diagnosis of invasive ductal pancreatic cancer compatible by computed tomography imaging, and followed-up until death or for 180 days or longer. |
| PubMedID- 26264026 | Pancreatic ductal adenocarcinoma (pdac) comprises 90% of all pancreatic cancer cases, and is an exocrine tumor arising from ductal or acinar cells [2] with a mortality rate of nearly 100% within 2 years, a statistic which has not declined over the past decades despite growing knowledge of the disease [3]. |
| PubMedID- 24007603 | Sample sizes are provided in table 1. confidence intervals for auc were calculated by taking 2000 stratified bootstrap samples; b auc, area under the receiver operating characteristic curve; pdac, pancreatic ductal adenocarcinoma (analogous to use of the term pancreatic cancer elsewhere in this report); c no significant difference in auc was noted between the aucs of sycn and reg1b with that of ca19.9 (p > 0.4). |
| PubMedID- 25500542 | Pancreatic ductal adenocarcinoma (pdac) comprises >90% of pancreatic cancers and is one of the most deadly cancer diseases in the western world despite its comparably low incidence.1, 2 clinical outcome is poor with only 5% of cases surviving up to 5 years after diagnosis.1, 3 pdac arises from precursor ductal lesions termed pancreatic intraepithelial neoplasia, tends to rapidly invade in surrounding tissues, and to metastasize to other organs, primarily the liver, while it is highly resistant to chemo- and radiation therapy.2 hence, it is of utmost importance to fully elucidate the underlying molecular mechanisms of pdac in order to develop novel therapeutic strategies. |
| PubMedID- 22421714 | Although 300 procedures were performed during this period; for the present study, we included only those cases diagnosed to be adenocarcinoma or other type of pancreatic cancers (n=229) for comparative purposes. |
| PubMedID- 22655256 | In addition to sporadic adenocarcinoma, an increased risk of pancreatic cancer has been demonstrated among persons with a family history of pancreatic cancer. |
Page: 1